Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis
Abstract The progression of idiopathic pulmonary fibrosis (IPF) is assessed through serial monitoring of forced vital capacity (FVC). Currently, data regarding the clinical significance of longitudinal changes in diffusing capacity for carbon monoxide (DLCO) is lacking. We investigated the prognosti...
Main Authors: | Hyeonsu Lee, So Yeon Kim, Young Sik Park, Sun Mi Choi, Jong Hyuk Lee, Jimyung Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-59649-5 |
Similar Items
-
Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
by: V. Cottin
Published: (2012-06-01) -
Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?
by: U. Costabel
Published: (2011-09-01) -
Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
by: Cheng-Yu Chang, et al.
Published: (2023-10-01) -
Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
by: Eunhye Bae, et al.
Published: (2022-11-01) -
Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)